BACKGROUND: Several new polyomaviruses have been discovered in the last decade, including Merkel cell polyomavirus (MCPyV). Little is known about the natural history of the more recently discovered polyomaviruses. We estimated the incidence, prevalence, and persistence of 9 polyomaviruses (MCPyV, BK polyomavirus, KI polyomavirus, JC polyomavirus, WU polyomavirus, Human polyomavirus 6 [HPyV6], HPyV7, HPyV9, and Trichodysplasia spinulosa-associated polyomavirus) and examined factors associated with MCPyV infection in a prospective cohort of 209 men initially enrolled in the HPV Infection in Men (HIM) study. METHODS: Participants enrolled at the US site of the HIM study were recruited into a substudy of cutaneous viral infections and followed for a median of 12.6 months. Eyebrow hair and normal skin swab specimens were obtained at each study visit, and the viral DNA load was measured using multiplex polymerase chain reaction. RESULTS: MCPyV infection showed the highest prevalence (65.1% of normal skin swab specimens and 30.6% of eyebrow hair specimens), incidence (81.7 cases per 1000 person-months among normal skin swab specimens, and 24.1 cases per 1000 person-months among eyebrow hair specimens), and persistence (85.8% of normal skin swab specimens and 58.9% of eyebrow hair specimens) among all polyomaviruses examined. Age of >44 years (odds ratio [OR], 2.11; 95% confidence interval [CI], 1.03-4.33) and Hispanic race (OR, 2.64; 95% CI, 1.01-6.88) were associated with an increased prevalence of MCPyV infection in eyebrow hair and normal skin swab specimens, respectively. CONCLUSION: MCPyV infection is highly prevalent in adults, with age and race being predisposing factors.
BACKGROUND: Several new polyomaviruses have been discovered in the last decade, including Merkel cell polyomavirus (MCPyV). Little is known about the natural history of the more recently discovered polyomaviruses. We estimated the incidence, prevalence, and persistence of 9 polyomaviruses (MCPyV, BK polyomavirus, KI polyomavirus, JC polyomavirus, WU polyomavirus, Human polyomavirus 6 [HPyV6], HPyV7, HPyV9, and Trichodysplasia spinulosa-associated polyomavirus) and examined factors associated with MCPyV infection in a prospective cohort of 209 men initially enrolled in the HPV Infection in Men (HIM) study. METHODS: Participants enrolled at the US site of the HIM study were recruited into a substudy of cutaneous viral infections and followed for a median of 12.6 months. Eyebrow hair and normal skin swab specimens were obtained at each study visit, and the viral DNA load was measured using multiplex polymerase chain reaction. RESULTS: MCPyV infection showed the highest prevalence (65.1% of normal skin swab specimens and 30.6% of eyebrow hair specimens), incidence (81.7 cases per 1000 person-months among normal skin swab specimens, and 24.1 cases per 1000 person-months among eyebrow hair specimens), and persistence (85.8% of normal skin swab specimens and 58.9% of eyebrow hair specimens) among all polyomaviruses examined. Age of >44 years (odds ratio [OR], 2.11; 95% confidence interval [CI], 1.03-4.33) and Hispanic race (OR, 2.64; 95% CI, 1.01-6.88) were associated with an increased prevalence of MCPyV infection in eyebrow hair and normal skin swab specimens, respectively. CONCLUSION: MCPyV infection is highly prevalent in adults, with age and race being predisposing factors.
Authors: Markus Schmitt; I G Bravo; Peter J F Snijders; Lutz Gissmann; Michael Pawlita; Tim Waterboer Journal: J Clin Microbiol Date: 2006-02 Impact factor: 5.948
Authors: Jonhan Ho; Jaroslaw J Jedrych; Huichen Feng; August A Natalie; Lisa Grandinetti; Ezra Mirvish; Maria M Crespo; Dhiraj Yadav; Kenneth E Fasanella; Siobhan Proksell; Shih-Fan Kuan; Diana V Pastrana; Christopher B Buck; Yoko Shuda; Patrick S Moore; Yuan Chang Journal: J Infect Dis Date: 2014-09-17 Impact factor: 5.226
Authors: I L Boxman; R J Berkhout; L H Mulder; M C Wolkers; J N Bouwes Bavinck; B J Vermeer; J ter Schegget Journal: J Invest Dermatol Date: 1997-05 Impact factor: 8.551
Authors: I Lasithiotaki; K M Antoniou; S P Derdas; E Sarchianaki; E K Symvoulakis; A Psaraki; D A Spandidos; E N Stathopoulos; N M Siafakas; G Sourvinos Journal: Int J Cancer Date: 2013-02-27 Impact factor: 7.396
Authors: Rossybelle P Amorrortu; Neil A Fenske; Basil S Cherpelis; Laxmi Vijayan; Yayi Zhao; Juliana Balliu; Jane L Messina; Vernon K Sondak; Anna R Giuliano; Tim Waterboer; Michael Pawlita; Tarik Gheit; Massimo Tommasino; Dana E Rollison Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-08-19 Impact factor: 4.254
Authors: S S Hampras; M Tommasino; Y Zhao; J L Messina; A R Giuliano; N A Fenske; B Cherpelis; R S Hesterberg; A A Akuffo; R P Amorrortu; J Balliu; L Vijayan; T Gheit; P K Epling-Burnette; D E Rollison Journal: Br J Dermatol Date: 2019-02-10 Impact factor: 9.302
Authors: Rossybelle P Amorrortu; Yayi Zhao; Neil A Fenske; Basil S Cherpelis; Jane L Messina; Anna R Giuliano; Vernon K Sondak; Michael J Schell; Sandrine Mckay-Chopin; Tarik Gheit; Tim Waterboer; Massimo Tommasino; Dana E Rollison Journal: J Infect Dis Date: 2022-09-28 Impact factor: 7.759
Authors: Anala Gossai; Tim Waterboer; Anne G Hoen; Shohreh F Farzan; Heather H Nelson; Angelika Michel; Martina Willhauck-Fleckenstein; Brock C Christensen; Ann E Perry; Michael Pawlita; Margaret R Karagas Journal: Cancer Med Date: 2016-02-21 Impact factor: 4.452